| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 81.28B | 80.24B | 72.22B | 79.43B | 80.52B | 70.57B |
| Gross Profit | 16.94B | 16.09B | 11.68B | 11.57B | 17.97B | 16.69B |
| EBITDA | 7.49B | 9.00B | 4.76B | 49.00M | 6.29B | 7.14B |
| Net Income | 1.73B | 2.64B | -1.04B | -4.94B | 1.50B | 2.17B |
Balance Sheet | ||||||
| Total Assets | 121.26B | 122.30B | 125.42B | 119.03B | 117.74B | 105.76B |
| Cash, Cash Equivalents and Short-Term Investments | 9.07B | 9.43B | 11.58B | 11.14B | 10.37B | 8.46B |
| Total Debt | 40.27B | 39.38B | 42.68B | 35.27B | 26.76B | 21.99B |
| Total Liabilities | 64.57B | 65.06B | 68.50B | 62.53B | 55.16B | 47.17B |
| Stockholders Equity | 58.57B | 58.47B | 56.13B | 54.08B | 59.18B | 57.23B |
Cash Flow | ||||||
| Free Cash Flow | -1.52B | 712.00M | -5.70B | -6.69B | -2.43B | -2.34B |
| Operating Cash Flow | 2.97B | 5.12B | 1.16B | -575.00M | 3.99B | 3.69B |
| Investing Cash Flow | -3.46B | -3.24B | -7.14B | -6.05B | -7.40B | -7.30B |
| Financing Cash Flow | -1.12B | -4.70B | 5.48B | 6.67B | 4.93B | 1.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥44.54B | 15.81 | ― | 1.92% | -0.86% | 17.65% | |
75 Outperform | ¥26.81B | 14.08 | ― | 2.47% | 3.53% | 8.36% | |
67 Neutral | ¥32.74B | 17.11 | ― | 2.37% | -11.70% | -54.82% | |
66 Neutral | ¥24.28B | 10.69 | ― | 3.84% | -3.41% | -12.83% | |
66 Neutral | ¥22.88B | 22.03 | ― | 4.62% | 7.19% | ― | |
64 Neutral | ¥23.21B | 13.39 | ― | 4.27% | 5.72% | 28.92% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Arakawa Chemical Industries, Ltd. reported a 3.3% increase in net sales for the three months ended June 30, 2025, compared to the same period in 2024. However, the company experienced a significant drop in profit attributable to owners of the parent, which decreased by 70.4%. Despite the challenges, the company maintains a stable equity ratio and has forecasted an increase in net sales and operating profit for the fiscal year ending March 31, 2026.